PRODUCTION AND SELECTION OF TUMOR UBER REACTIVE IMMUNE CELLS (TURICS)
The present invention relates to a method for producing a T-cell product containing tumor uber reactive immune cells (TURICs) and a composition containing at least one T-cell product with TURICs for use in treatment of a cancer patient..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 15. Juli Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
DODOO ERNEST [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-07-15, Last update posted on www.tib.eu: 2024-04-03, Last updated: 2024-04-09 |
|---|
| Patentnummer: |
US2021214686 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA003253325 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA003253325 | ||
| 003 | DE-627 | ||
| 005 | 20240409143744.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240409s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA003253325 | ||
| 035 | |a (EPA)US2021214686 | ||
| 035 | |a (EPA)67667805 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a DODOO ERNEST |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PRODUCTION AND SELECTION OF TUMOR UBER REACTIVE IMMUNE CELLS (TURICS) |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-07-15, Last update posted on www.tib.eu: 2024-04-03, Last updated: 2024-04-09 | ||
| 520 | |a The present invention relates to a method for producing a T-cell product containing tumor uber reactive immune cells (TURICs) and a composition containing at least one T-cell product with TURICs for use in treatment of a cancer patient. | ||
| 650 | 4 | |a bio | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a MAEURER MARKUS |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 15. Juli |
| 773 | 1 | 8 | |g year:2021 |g day:15 |g month:07 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/67667805/publication/US2021214686A1?q=US2021214686 |m X:VERLAG |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 15 |c 07 | ||